Recalibrate Health

Recalibrate HealthRecalibrate Health
Recalibrate Health

Recalibrate Health

AI-powered platform for personalized metabolic health and chronic disease management.

DR 832021ActiveSan Francisco, United States
Rate

About

Recalibrate.ai is a premium domain name for businesses focused on AI innovation, embodying precision tuning and intelligent optimization. It is ideal for entities aiming to lead in AI development by conveying refinement, problem-solving, and continuous improvement. The domain is positioned as a strategic asset for companies offering reliable, accurate, and ethically aligned AI solutions.
Frequently asked

What does Recalibrate Health do?

Recalibrate.ai is a premium domain name for businesses focused on AI innovation, embodying precision tuning and intelligent optimization. It is ideal for entities aiming to lead in AI development by conveying refinement, problem-solving, and continuous improvement. The domain is positioned as a strategic asset for companies offering reliable, accurate, and ethically aligned AI solutions.

What is Recalibrate Health's revenue?

StartupHub estimates Recalibrate Health's annual revenue at $1.5M (range $509K to $2.4M, 29% confidence), based on comparable companies in the sector.

What is Recalibrate Health's valuation?

StartupHub estimates Recalibrate Health's effective valuation at $35.5M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Recalibrate Health raised?

Recalibrate Health has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Recalibrate Health headquartered?

Recalibrate Health is headquartered in San Francisco, United States.

When was Recalibrate Health founded?

Recalibrate Health was founded in 2021.

What industry does Recalibrate Health operate in?

Recalibrate Health operates in HealthTech, MedTech, Digital Health, Chronic Disease Management, Metabolic Health, AI-Driven Health.

Comments

No comments yet. Be the first to share your take.